Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-11-25

Clinical Trial Update: Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]

View source ↗

Summary

This update notes emergency administration of EPI-743 to a single patient with Leber's hereditary optic neuropathy, and indicates the trial is no longer availab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPI-743

Snippet

Sponsor: Edison Pharmaceuticals Inc | Conditions: Leber's Hereditary Optic Neuropathy | Status: NO_LONGER_AVAILABLE